Results of a Single-Institution Experience With Dose-Escalated Chemoradiation for Locally Advanced Unresectable Non-Small Cell Lung Cancer

被引：0
|
作者：
Bernard, M. [1 ]
Glaser, S. M. [1 ]
Gill, B. S. [1 ]
Beriwal, S. [1 ]
Heron, D. E. [2 ]
Luketich, J. [3 ]
Friedland, D. [4 ]
Socinski, M. [4 ]
Greenberger, J. S. [5 ]
机构：
[1] Univ Pittsburgh, Inst Canc, Dept Radiat Oncol, Pittsburgh, PA USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[3] Univ Pittsburgh, Inst Canc, Dept Thorac Surg 2, Pittsburgh, PA USA
[4] Univ Pittsburgh, Inst Canc, Dept Med Oncol, Pittsburgh, PA USA
[5] UPMC Shadyside Hosp, Pittsburgh, PA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1758
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3105
引用
收藏
页码：E449 / E449
页数：1
相关论文
共 50 条
  • [31] Definitive Chemoradiation and Durvalumab Consolidation for Locally Advanced, Unresectable KRAS-mutated Non-Small Cell Lung Cancer
    Guo, Matthew Z.
    Murray, Joseph C.
    Ghanem, Paola
    Voong, K. Ranh
    Hales, Russell K.
    Ettinger, David
    Lam, Vincent K.
    Hann, Christine L.
    Forde, Patrick M.
    Brahmer, Julie R.
    Levy, Benjamin P.
    Feliciano, Josephine L.
    Marrone, Kristen A.
    CLINICAL LUNG CANCER, 2022, 23 (07) : 620 - 629
  • [32] Keeping a track on leptomeningeal disease in non-small cell lung cancer: A single-institution experience with CNSide™
    Puri, Sonam
    Malani, Rachna
    Chalmers, Anna
    Kerrigan, Kathleen
    Patel, Shiven B.
    Monynahan, Kelly
    Cannon, Laura
    Blouw, Barbara
    Akerley, Wallace
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [33] A single institution's experience in the use of bevacizumab in advanced non-small cell lung cancer
    Schreiber, A. M.
    Liekensohn, A.
    Kadaria, D.
    Allen, J. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Outcomes of lobectomy following chemoradiation for locally advanced non-small cell lung cancer
    Farlow, Erin Corinne
    Kim, Anthony W.
    Liptay, Michael J.
    Warren, William H.
    Basu, Sanjib
    Bonomi, Philip
    Faber, L. Penfield
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S300 - S301
  • [35] Induction Chemotherapy and Chemoradiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer: A Single-Institution Review of Two Different Regimens
    Kocak, Mihriban
    Ozkan, Alper
    Mayadagli, Alpaslan
    Parlak, Cem
    Bilici, Ahmet
    Seker, Mesut
    Ustaalioglu, Bala Basak Oven
    Gumus, Mahmut
    Eren, Makbule
    Karabulut, Sule Gul
    Oruc, Fatih
    CLINICAL LUNG CANCER, 2009, 10 (02) : 124 - 129
  • [36] Durvalumab Adjuvant to Chemoradiation for Patients With Locally Advanced Non-Small Cell Lung Cancer: Real World Experience
    Haakensen, V. D.
    Nymoen, H. M.
    Langberg, C. W.
    Horndalsveen, H.
    Farooqi, S.
    Bjaanaes, M.
    Helland, A.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1045 - S1045
  • [37] Dose-Escalated Hypofractionated Intensity Modified Radiation Therapy (IMRT) With Concurrent Chemotherapy for Inoperable or Unresectable Non-Small Cell Lung Cancer (NSCLC)
    Kim, J.
    Ghosh, S.
    Roa, W. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S545 - S545
  • [38] Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung Cancer
    Loh, Jerold
    Low, Jia Li
    Sachdeva, Manavi
    Low, Peter Q. J.
    Wong, Rachel Su Jen
    Huang, Yiqing
    Chia, Puey Ling
    Soo, Ross A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (09) : 913 - 926
  • [39] Locally advanced, unresectable non-small cell lung cancer - New treatment strategies
    Johnson, DH
    CHEST, 2000, 117 (04) : 123S - 126S
  • [40] SIGNIFICANCE OF CONSOLIDATION CHEMOTHERAPY IN UNRESECTABLE, LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER
    Akamatsu, Hiroaki
    ANNALS OF ONCOLOGY, 2014, 25
12345